NuCalm
NuCalm (www.NuCalm.com) is a patented, drug-free, clinically proven neuroscience technology that enables users to change their mental state on demand. Since 2014, NuCalm has been a foundational technology for the Institute’s cancer treatment program. Dr. Hranicky says, “Over four decades, I have used a range of techniques and therapies to help patients manage stress, but none has provided consistently predictable and reliable outcomes -until NuCalm. Regular use builds resilience, lowers inflammation, builds immune strength, and, most importantly, provides precious moments of peace of mind and hope, while also improving sleep quality.”
James Poole, neuroscience tech pioneer and President CEO of Solace Lifesciences, Inc., maker of NuCalm, says a key to preserving good health and fighting effects of cancer is resilience. “Think of resilience as your mind and body’s ‘rainy day fund.’ Patients and healthy individuals alike can build resilience with regular NuCalm use. NuCalm acts like a reset button that dramatically lowers the stress response and allows the body’s natural healing processes to thrive. When a person learns they have cancer, often they become stressed, fearful and confused,” says Poole. “They can’t relax. The body’s resulting stress response allows the cancer to take over, and even accelerate the patient’s depreciation. NuCalm predictably and rapidly puts the brakes on the stress response, giving them peace of mind, clarity, balance, and improved sleep quality. Dr. Hranicky’s multi-pronged approach – incorporating NuCalm — helps the mind and body to fight back.”
James Poole
– President & CEO of Solace Lifesciences, Inc., maker of NuCalm
